Status:
COMPLETED
Ultrasound-Guided Percutaneous Neuromodulation in the Strength of CrossFit Athletes
Lead Sponsor:
Universidad de Zaragoza
Conditions:
Healthy
CrossFit
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The origin of CrossFit (CF) dates back to 1995 when Greg Glassman opened the first facility dedicated to the sport he named CF in Santa Cruz, California. However, the dissemination and promotion of th...
Detailed Description
The study aims to: * Analyze whether 3 sessions of ultrasound-guided percutaneous neuromodulation (US-PNM) are more effective than 1 session of US-PNM for shoulder rotation muscle strength in healthy...
Eligibility Criteria
Inclusion
- Be between 18 and 65 years old
- Have at least 1 year of experience in CrossFit training
Exclusion
- Have not undergone any previous surgeries
- Have no pathology that causes any type of pain
- Have no physical impairment that would hinder dynamometry measurements (muscle injuries, joint instability, joint inflammation, etc.)
- Have no contraindications for the application of Ultrasound-Guided Percutaneous Neuromodulation (US-PNM) such as trypanophobia, pregnancy, epilepsy, or pacemakers.
Key Trial Info
Start Date :
September 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2024
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT06529770
Start Date
September 15 2024
End Date
December 13 2024
Last Update
December 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Canvi Crossfit
Tavernes de la Valldigna, Valencia, Spain, 46760
2
Universidad de Zaragoza
Zaragoza, Zaragoza, Spain, 50009